Laxative
Pregnancy: A — safe throughout pregnancy
Lactulose
Brand names: Lactulose Solution
Adult dose
Dose: Constipation: 15ml BD. Hepatic encephalopathy: 30–50ml TDS (titrate to 2–3 soft stools/day)
Route: Oral
Frequency: Twice daily (constipation); 3–4 times daily (HE)
Max: Hepatic encephalopathy: 200ml/day
Onset 24–48h. Mix with water or juice. Hepatic encephalopathy: aim for 2–3 loose stools per day — acidifies colon, reduces NH₃ absorption.
Paediatric dose
Dose: 0.5 mL/kg
Route: Oral
Frequency: Twice daily
Max: 15ml
Age bands
- 0–12m: 2.5ml BD
- 12–60m: 5ml BD
- 60–144m: 10ml BD
Paediatric weight-based calculator
Clinical pearls
- Hepatic encephalopathy: lactulose acidifies the colon — NH₃ converted to NH₄⁺ which is not absorbed. First-line treatment (NICE NG215).
- Target 2–3 soft stools per day in HE — reduce dose if diarrhoea.
- SONIC trial: rifaximin + lactulose superior to lactulose alone for secondary prevention of overt HE.
- Not absorbed — osmotic agent. Onset 24–48h (slower than stimulant laxatives).
Contraindications
- Galactosaemia
- Intestinal obstruction
- Severe inflammatory bowel disease
Side effects
- Flatulence and bloating (very common — especially initially)
- Abdominal cramps
- Diarrhoea (if overused)
- Nausea
Interactions
- Antacids: may reduce lactulose efficacy (neutralise colonic acidification)
Monitoring
- Stool frequency
- electrolytes if high doses (diarrhoea)
- ammonia level (HE)
Reference: BNFc; NICE NG215 Cirrhosis; NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021